Literature DB >> 7955455

Mineralocorticoid and glucocorticoid status in idiopathic haemochromatosis.

C H Walsh1, A L Murphy, S Cunningham, T J McKenna.   

Abstract

OBJECTIVE: A number of studies have suggested that both primary (Addison's disease) and secondary adrenal failure may be caused by idiopathic haemochromatosis. There is little information on mineralocorticoid secretion. We have assessed the mineralocorticoid and glucocorticoid status of patients with idiopathic haemochromatosis.
DESIGN: Cross-sectional study. PATIENTS: Eighteen males and one female with confirmed idiopathic haemochromatosis were investigated. Seven of the subjects had hepatic cirrhosis and three had hypogonadotrophic hypogonadism. MEASUREMENTS: A short Synacthen (tetracosactrin) test was undertaken in addition to an overnight metyrapone test and an insulin stress test. In addition, plasma aldosterone (PA) and plasma renin activity (PRA) were measured in a group of patients in the basal state and again in the upright position.
RESULTS: The short Synacthen test, overnight metyrapone test and insulin stress test were normal in all subjects. The PA, PRA, and PA/PRA ratios in the upright position were not significantly different in the patients with idiopathic haemochromatosis compared to control subjects.
CONCLUSION: In this patient population, no abnormality of either the pituitary adrenal axis or mineralocorticoid status was detected. Adrenocortical dysfunction is likely to be exceptionally rare in idiopathic haemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955455     DOI: 10.1111/j.1365-2265.1994.tb02574.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Thyroid function in haemochromatosis.

Authors:  M S Murphy; C H Walsh
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

2.  Mineralocorticoid status and endocrine dysfunction in severe hemochromatosis.

Authors:  L M Hempenius; P S Van Dam; J J Marx; H P Koppeschaar
Journal:  J Endocrinol Invest       Date:  1999-05       Impact factor: 4.256

Review 3.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

4.  All that is hypogonadal in haemochromatosis is not due to iron deposition.

Authors:  E P O'Sullivan; J H McDermott; C Howel Walsh
Journal:  Ir J Med Sci       Date:  2007-03       Impact factor: 1.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.